chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dizziness; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and PYREXIA (Fever) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     The patient's past medical history included Surgery (surgery on throat) on 20-Apr-2021.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced DIZZINESS (Dizziness) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. On 05-Feb-2021, DIZZINESS (Dizziness) and PYREXIA (Fever) had resolved.            No Concomitant medications were reported. No Treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Address of the reporter was added, patient age was added, pregnancy status was added as NO, first and second  dose start date was added, Event was added with start and stop date On 12-Jul-2021: Follow-up information received on 12-JUL-2021; Events stop date and outcome updated.
Hives developed on my left elbow on Saturday afternoon.  More hives appeared on my inner forearm on Sunday morning.
the day p/vax pt exp a large painful red bump in the breast on the same side vax given it lasted 4 days;
On 8/31/18 - This 2 month old (former 38 3/7 full term healthy infant) has first set of vaccines. Her am spitting up escalated to intermittent spitting up by 5 days after 8/31/18. Not breastfeeding as much as usual. When evaluated 9/10/18 had lost 1 lb 7 oz (12.5% from the previous visit) at 2 month wcc when vaccines were given. She was evaluated at the Hospital ER. Loose stool has started. BioFire rapid test results only found Rotovirus A pathogen from nasal + stool samples. After normal abdominal ultrasound, lab work and IV fluids she was sent home.
pt recvd vax & small burised area noted @ site;pt went to lab for blood work came bakc pt's lt uppeer arm pink 3x3" size & 1/2" size raised bruise noted;
I have not started my period since my second dose. My cycles are always regular. I?ve only had a little spotting.  I am 3 weeks late as of the report.
Painful acute genital ulcers; This spontaneous case was reported by a pharmacist and describes the occurrence of GENITAL ULCERATION (Painful acute genital ulcers) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028l20a) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis and Immunocompromised. Concomitant products included RITUXIMAB (RITUXAN) from 06-Nov-2020 to 10-May-2021 for Rheumatoid arthritis, LEVOTHYROXINE SODIUM (SYNTHROID) and SPIRONOLACTONE for an unknown indication.    On 01-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced GENITAL ULCERATION (Painful acute genital ulcers). The patient was treated with CLOBETASOL for Genital ulceration, at an unspecified dose and frequency and LIDOCAINE for Genital ulceration, at an unspecified dose and frequency. At the time of the report, GENITAL ULCERATION (Painful acute genital ulcers) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Herpes virus test: negative (Negative) negative and negative (Negative) negative. On an unknown date, Varicella virus test: negative (Negative) negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient thought she got herpes and seen by OBGYN (Obstetrician-Gynecologists) right away. Felt very painful. The patient was referred to ID OBGYN and she was sure that the side effect was due to vaccine.   This case was linked to MOD-2021-370939, MOD-2021-371168 (Patient Link).
Patient w/ history of high grade invasive ductaal carcinoma, presented with high fever and myalgias after receiving 3rd dose of Pfizer COVID vaccine. Fever at 3AM, fever at 6AM, became unintelligible and went to emergency center, episode of nausea, diffuse myalgias, discharged from emergency center.
24 hours later after the second vaccine I began to feel tightness in my chest and my throat that felt similar to GERD. Simultaneously I got the chills and had tingling in my head with a slight headache. I had to go to bed because I didn't know what to do so I took a atarax and protonix. 707 p.m. same day felt a little better in terms of the throat tightening but still feeling the same sensations very uncomfortable.
About ten minutes after he received his shot he felt dizzy and that he may pass out. He did, in fact, faint and was slightly continent. He was diaphoretic, and shaky. His blood pressure was 169/110 to which he says is "his normal", pulse in the 90s, Sp02 was anywhere from 97-98%. When the patient was sat up his blood pressure would drop. He was monitored by paramedic, did not receive treatment other than water and gingerale. He did not want to go to the hospital. Once he was feeling better he went home with his wife.
Pt recvd vax & exp paresthesias, numbness & areas of pain all four extremities. Slight improvement by 08/11/97. Addl info recvd by provider 10/06/97 & 12/01/97. Vax provider stated pt declined to discuss event or be evaluated by provider
Extreme headache, nausea, vomiting, diarrhea, sore throat, swollen glands, coughing, a lot of congestion and blowing of the nose, chest congestion and pressure restlessness or sleeplessness. No fever but had an extreme metal taste in mouth once started on PAXLOVID also experienced extreme loss of appetite.
a little bit of nausea; tiredness; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 17Feb2021 (lot number and expiry date unknown) as dose 1, single, for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On unspecified date, the patient experienced a little bit of nausea and tiredness. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
A 48 year old male patient received an initial dose of Typhim Vi, lot number Z0572-2, administered intra-muscularly in the left deltoid and an initial dose of Hepatitis A Vaccine (lot number AHAVB106AA, administered intra-muscularly in the right deltoid. Later that same day (exact latency not reported), the patient experienced pain at the Typhim Vi injection site. The pain radiated to the collarbone and mid upper arm. As per the reporter, a 23 gauge one inch safety syringe was used to administer the Typhim Vi product. At the time of this report the patient had not recovered from the events. Follow up information received on 27 October 2006. Per the reporter, the patient received the vaccination at the worksite. The employee followed up with his personal doctor. The contact information for the personal physician was provided. No other medical information was provided.
Tiredness, fatigue, general physical weakness. Had to leave work, slept and rest.
Excessive bleeding after shot given. Redness, swelling, itching, warm to touch at injection site a couple of days after shot given.
fatigue; basically unable to eat or even drink; Pain on under her shoulder; she got chills; severe shaking; Nausea, nauseous; feel still hot; This is a spontaneous report from a contactable consumer (patient's parent). A 23-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date: Unknown), via an unspecified route of administration on 14Mar2021 (at the age of 23-years-old) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included autoimmune conditions, colitis ulcerative, connective tissue disorder/lupus, inflammatory problems; all from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously took antibiotics for 10 years for one disease, naltrexone, mesalamine, loxoprofen for anxiety. The reporter stated that her daughter (patient) was 23 years old and had taken medications for autoimmune conditions, the patient had ulcerative colitis and connective tissue disorder/lupus and had got both those condition because she was on unspecified antibiotics for 10 years for one disease and then she ended up with lot of inflammatory problems. So, she was on Naltrexone, Mesalamine and Loxoprofen for anxiety. The patient took the first shot of bnt162b2 on 14Mar2021 and had severe effects after 20 minutes, she got chills and severe shaking and nausea and she felt still hot that they went to the emergency room, her shaking was subsided, the reporter stated might be after 3 to 5 minutes, so basically the patient got Zofran as treatment for her nausea and came home and in the next two days she was nauseous and fatigue and basically unable to eat or even drink and had pain on under her shoulder which was not a big deal. The reporter questioned if the patient should take the second shot because she had received like a pretty strong response to the first and will the 2nd shot create any Inflammatory disorder that she didn't have at that point or do you have any information or worse. Further she stated, basically a quick question so what causes that chill and shaking, was that a shock kind of response or was that vaccine reaction. Therapeutic measures were taken as a result of nausea. The outcome of all the events was unknown while shaking was recovering.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Caller stated that he is immunocompromised; lymphoma; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (Pfizer-BioNTech COVID-19), administration date Jan2021 (Batch/Lot number: unknown) as dose 1, single, (Batch/Lot number: unknown) as dose 2, single(administration date is three weeks after the first dose) and administration date 11Aug2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. Patient is under a clinical study program which needing him to take 2 pills 12 hours apart. he is on this study for 7 or 8 years already. The following information was reported: IMMUNODEFICIENCY (medically significant), outcome "unknown", described as "Caller stated that he is immunocompromised"; LYMPHOMA (medically significant), outcome "unknown", described as "lymphoma". Patient stated that he is somehow immunocompromised because of this and he needs to "keep track of his lymphoma."  The lot number for bnt162b2 was not provided and will be requested during follow up.
Pt is a 27 yr/o female who presents with general symptoms Had Covid vaccine yesterday Today describes multiple symptoms including headache, fatigue, low energy, chest pressure, shortness of breath, swelling, rash, flushed feeling, etc. No history of true syncope or palpitations No definite fever, chills No history of blood clot or bleeding disorder No current cough or bloody cough
allergic reactions (flayed skin); This non-serious case was reported by a pharmacist via call center representative and described the occurrence of excoriation in a female patient who received Flu unspecified (Influenza vaccine) for prophylaxis.   Co-suspect products included PNEUMOCOCCAL VACCINE (PNEUMONIA VACCINE (TRADE NAME UNKNOWN)) for prophylaxis.   On an unknown date, the patient received Influenza vaccine and PNEUMONIA VACCINE (TRADE NAME UNKNOWN). On an unknown date, an unknown time after receiving Influenza vaccine, the patient experienced excoriation (Verbatim: allergic reactions (flayed skin)). The outcome of the excoriation was unknown.   It was unknown if the reporter considered the excoriation to be related to Influenza vaccine.     It was unknown if the company considered the excoriation to be related to Influenza vaccine.   Additional Information: GSK receipt date: 11-JUL-2023 The pharmacist had a female patient who experienced allergic reactions (flayed skin) after a pneumonia and flu vaccine (no brand name available) and they were figuring out whether administer Shingrix vaccine or not. The reporter did not consent to follow up. The reporter called back Healthcare professional in order to clarify influenza brand but Pharmacy was closed. It was unknown if the reporter considered the excoriation to be related to PNEUMONIA VACCINE .
pt recv vax 1/20/98 & last menstrual period on 12/24/97 & pt became pregnant;EDD 10/1/98 pregnancy was confirmed by urine HCG;ultrasound @ 16 wk revealed no gross abn/triple screen wnl;exp pharyngitis;exp poss UTi & basilar pneumonia.On 28-MAY-1998 she was treated with NONISTAT  DERM bid for monilial labial infection and with GYNE-LOTRIMIN CREAM for 7 days for a vaginal candidiasis which was confirmed by a cervical culture. On 03-JUN-1998 the patient placed on therapy with AMOXIL 250 mg tid for 10 days for her group B strep UTI and her vaginal infection. On 19-AUG-1998 she was treated with ZOVIRAX cream for Herpes Simplex I. On 18-SEP-1998 the patient gave birth, via c-section, to a male baby who weighted 3600 grams. At the time of the report, it was unknown if the baby had any congenital abnormalities. No further information is available.
My period was 2 weeks late which is uncommon and when it did start the worse cramps, the period was lighter than normal, and I was extra fatigued.
I woke up with a 102 temperature, severe body aches, shaking, headache and nausea. This occurred for 2 days. On the second day the headache worsened and I was also experiencing vomiting and chest pains. On the third day I woke up with just a headache but now a sore throat. On the fourth day I now have cold symptoms and are very weak.
Fever developed eight hours after vaccination. Baby was fussy. Fever lasted approximately 30 hours.
10 days post vaccine red, warm, itchy area approx. 7.5 cm x 7.5 cm at the injection site.  No s/s of cellulitis.
I have a constant ringing in my ears and sometimes a ringing/reverberation sound when people talk or listening to almost anything.  It has not improved overtime.
immunocompromised; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID.  An 88-year-old patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 immunisation; Bnt162b2 (Dose 2), for COVID-19 immunisation; Bnt162b2 (Dose 3 (booster)), for COVID-19 immunisation; Bnt162b2 (Dose 4 (booster)), for COVID-19 immunisation. The following information was reported: IMMUNODEFICIENCY (medically significant), outcome "unknown", described as "immunocompromised". Clinical course: Patient was reported to be 88 years old and immunocompromised, have taken two shots primary series and three booster doses from Pfizer. Reporter was inquiring if patient should get another booster shot.   The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202200126653 same reporter/drug/event, different patient.;
(L) thigh with 12cm X 8cm area of erythema surrounding injection site.
Death within thirty days of vaccine.  Multiple co-morbidities and placed on hospice 12/28/20.
There was a rash in different parts of the body, sensitive to hot water, clothing. Hives where the clothes touched my body. I never got relive from it. Those places that didn't have the rash was also itchy. The doctor put me on steroid and it did not help. Didn't mentioned the vaccine to the doctor. Went back several times and there was no relive and there were marks on my skin. This went on till Jul2021. Went liver heat and went on detox - natural doctor and referred to acupuncturist and took herbs and that helped lightened but never fully gone until July 2021. Took my 2nd dose - the rash never went away after 1st and got worse after the 2nd dose. More inflamed more. Still sporadically feel this. Skin feels a little warmer.
her arthritis got really bad; could barely get out of bed; This is a spontaneous report received from contactable reporter(s) (Other HCP and Consumer or other non HCP) for a Pfizer sponsored program.  A 55 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Rheumatoid arthritis" (ongoing). Concomitant medication(s) included: ADVIL [IBUPROFEN]. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunization; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 immunization. The following information was reported: ARTHRITIS (non-serious), outcome "unknown", described as "her arthritis got really bad"; BEDRIDDEN (non-serious), outcome "unknown", described as "could barely get out of bed".  Additional information: The patient took Xeljanz XR 11mg tablet (30s), 1 tablet daily since 01Jan2013 for rheumatoid arthritis. The patient had to go off Xeljanz for a week when she got her covid booster.   The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Red rash on feet, legs, arms, torso, back & scalp. Started one or two spots and then became clusters with hard bumps and some blisters appears on the left & right above & below the waist.
Information has been received from a registered nurse concerning a 14 year old female with sulfonamide allergy, Penicillin allergy, and asthma who on 29-Oct-2008 was vaccinated at another office with GARDASIL (661766/0652X) intramuscularly in her left arm. Secondary suspected therapy included MENACTRA in her left arm and an unspecified influenza virus in her right arm. All 3 vaccines were received on the same day. The nurse stated that the patient developed a reaction after receiving the 3 vaccines. On 29-Oct-2008 the patient experienced pain bilaterally in her upper and lower back. The patient said her "mouth felt funny" but had no problem swallowing. The patient had ear pain on her right side and ear turned red. The patient also reported mild aches in thighs and knees and a fever of 101f with generalized body aches and fatigue. The patient was seen in the office of the reporter for these symptoms on 30-Oct-2008 and had a transient "hive like" rash on the underside of her left upper arm. The patient also had mild difficulty breathing (her peak flow rate was usually 500 and it dropped to 350). Subsequently, the patient recovered. Additional information has been requested.
Patient stated the vaccine given on 17FEB21 was given subcutaneously. Per my recollection the vaccine was administered per training protocols, which are  Intramuscular, at a 90 degree angle, and into the Deltoid.
Elbow is very inflamed and hand; This is a spontaneous report from a contactable consumer (parent). A 38-year-old male patient received first dose of BNT162B2 (; Solution for injection; Lot number: EL9266) via an unspecified route of administration on Saturday 13Feb2021 (at the age of 38-year-old) as single dose for COVID-19 immunization. Medical history included blood pressure. Concomitant medication included Lisinopril 10 mg taken for Blood pressure, Hydrochlorothiazide 25 mg taken for blood pressure started on an unspecified date. On 14Feb2021, Sunday after receiving vaccination, patient experienced that going down his arm, his elbow was very inflamed and his hand, had pain. Patient went to an urgent care because that's where our doctors sent us, and they said that it's inflammation from the shot. Patient was given 100 Motrin/Motrin 800 mg for the inflammation and the pain. Patient was due for the second dose on 06Mar2021. Outcome of the event was unknown.  Follow-up (12May2021): Follow-up attempts completed. No further information expected.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ADULT OBSTRUCTIVE SLEEP APNEA, MILD 11/26/2022 -- RECURRENCE OF SAME SYMPTOMS
Became very ill within 24 hours. Flu-like symptoms. Arm swollen and red.
Patient hospitalized for cellulitis of right hip/Infected prosthesis of right hip within 6 weeks of receiving COVID vaccination.
mom states 48hr p/vax pt had a 6hr screaming episode;mom took child to urgent care out of town & was told s/s may have been from vax (?allergic rxn), child had not prev allergic s/s to vax;
This spontaneous report was received from Registered Nurse regarding to a 13 month old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 13-JUN-2016, the patient was vaccinated with improperly stored VARIVAX (lot # L004649, expiry date 11-FEB-2017) (therapy type digital data logger) dosage regimen unknown. It was reported that the vaccine was exposed to a temperature excursion of 23 degree Celsius for a time frame of 1 hour and 29 minutes and the temperature was back in range. It was reported that the vaccine was not subjected to previous temperature excursion. Product quality complaint (PQC) was not filed. This is one of the several reports received form the same reporter. Additional information had been requested.
Felt shaky, started to have facial swelling and tongue swelling and had to take diphenhydramine.  Started to feel abdominal and chest tightness.  Taken to ER and given IV diphenhydramine and IV dexamethasone
Pt had the injection on 7/20 at approx 2:15 pm. She woke up at 5:00 am with severe pain in her (L) Deltoid. Shoulder was painful and hot to touch. By 1 pm it was swollen w/purple discoloration and warm to touch. She got a headache and took fluids thinking she was dehydrated. 2:00 PM: Full body aches, By Friday: minor chills felt better but arm was still swollen, red, hard and painful. She took 400mg Ibuprofen Q 4 hours during that time. She is now taking 200mg Q 4hrs. She denied SOB, chest pain, dizziness.